Dysfunctional Immune-Privilege In Morbid Obesity: Implications and Effect of Gastric Bypass Surgery

被引:0
作者
D R Cottam
P A Schaefer
G W Shaftan
L D G Angus
机构
来源
Obesity Surgery | 2003年 / 13卷
关键词
MORBID OBESITY; CANCER; APOPTOSIS; CHRONIC INFLAMMATION; L-SELECTIN; FAS ANTIGEN; CD62L; CD95; LYMPHOCYTE; NEUTROPHIL; FLOW CYTOMETRY; IMMUNE PRIVILEGE; BARIATRIC SURGERY; GASTRIC BYPASS;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link.We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Methods: Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD 69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. Results: The percentage of CD95+T cells was significantly elevated from controls (69.4% vs 56%, P=0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P=0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P=0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P=0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. Conclusion: The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.
引用
收藏
页码:49 / 57
页数:8
相关论文
共 50 条
  • [21] Wernicke's encephalopathy after bariatric gastric bypass surgery for morbid obesity
    Richard-Devantoy, Stephane
    Garre, Jean-Bernard
    Nicolas, Guillaume
    Rohmer, Vincent
    Salle, Agnes
    NUTRITION CLINIQUE ET METABOLISME, 2008, 22 (03): : 130 - 132
  • [22] Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity
    Renshaw, AA
    Rabaza, JR
    Gonzalez, AM
    Verdeja, JC
    OBESITY SURGERY, 2001, 11 (03) : 281 - 283
  • [23] A Preliminary Comparison of the Psychological Impact of Laparoscopic Gastric Banding and Gastric Bypass Surgery for Morbid Obesity
    Catherine R Delin
    Paul G Anderson
    Obesity Surgery, 1999, 9 : 155 - 160
  • [24] Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer
    Menendez, Pablo
    Villarejo, Pedro
    Padilla, David
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (05) : 296 - 298
  • [25] A preliminary comparison of the psychological impact of laparoscopic gastric banding and gastric bypass surgery for morbid obesity
    Delin, CR
    Anderson, PG
    OBESITY SURGERY, 1999, 9 (02) : 155 - 160
  • [26] Metabolic Complications of Bypass Surgery for Morbid Obesity
    Richard-Devantoy, S.
    Garre, J. B.
    Gohier, B.
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2009, 2 : 55 - 58
  • [27] Clinical Experience Using the Computerized Digital Stapling System in Open Gastric Bypass Surgery for Morbid Obesity
    Robert K Liem
    Paul H Niloff
    Obesity Surgery, 2003, 13 : 837 - 841
  • [28] Zinc Deficiency after Gastric Bypass for Morbid Obesity: a Systematic Review
    Kamal K. Mahawar
    Aparna Govil Bhasker
    Vivek Bindal
    Yitka Graham
    Usha Dudeja
    Muffazal Lakdawala
    Peter K. Small
    Obesity Surgery, 2017, 27 : 522 - 529
  • [29] Copper Deficiency after Gastric Bypass for Morbid Obesity: a Systematic Review
    Kumar, Parveen
    Hamza, Numan
    Madhok, Brijesh
    De Alwis, Nimantha
    Sharma, Manisha
    Miras, Alexander Dimitri
    Mahawar, Kamal K.
    OBESITY SURGERY, 2016, 26 (06) : 1335 - 1342
  • [30] Zinc Deficiency after Gastric Bypass for Morbid Obesity: a Systematic Review
    Mahawar, Kamal K.
    Bhasker, Aparna Govil
    Bindal, Vivek
    Graham, Yitka
    Dudeja, Usha
    Lakdawala, Muffazal
    Small, Peter K.
    OBESITY SURGERY, 2017, 27 (02) : 522 - 529